Walleye Trading »

Arcutis Biotherapeutics shares owned by Walleye Trading

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Walleye Trading from 13F filings

Historical chart of Walleye Trading investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Walleye Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Walleye Trading

Quarter filed Position value Share count Share price at filing
2023-12-31 $40k 12k 3.23
2022-06-30 $1.1M 50k 21.31
2022-03-31 $980k 51k 19.25

More positions owned by Walleye Trading

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A (META)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Intel Corporation Call Option (INTC)
Pdd Holdings Sponsored Ads Call Option (PDD)
Palo Alto Networks Put Option (PANW)
Alibaba Group Hldg Sponsored Ads (BABA)
Crowdstrike Hldgs Cl A Put Option (CRWD)

View all positions for Walleye Trading

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics